Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Return on Equity (2017 - 2025)

Historic Return on Equity for Lexaria Bioscience (LEXX) over the last 10 years, with Q4 2025 value amounting to 2.72%.

  • Lexaria Bioscience's Return on Equity fell 18700.0% to 2.72% in Q4 2025 from the same period last year, while for Nov 2025 it was 2.72%, marking a year-over-year decrease of 18700.0%. This contributed to the annual value of 2.23% for FY2025, which is 11200.0% down from last year.
  • As of Q4 2025, Lexaria Bioscience's Return on Equity stood at 2.72%, which was down 18700.0% from 2.78% recorded in Q3 2025.
  • Lexaria Bioscience's Return on Equity's 5-year high stood at 0.0% during Q3 2021, with a 5-year trough of 2.78% in Q3 2025.
  • Its 5-year average for Return on Equity is 1.02%, with a median of 0.88% in 2022.
  • As far as peak fluctuations go, Lexaria Bioscience's Return on Equity surged by 10400bps in 2024, and later plummeted by -21200bps in 2025.
  • Lexaria Bioscience's Return on Equity (Quarter) stood at 0.17% in 2021, then tumbled by -451bps to 0.91% in 2022, then plummeted by -108bps to 1.89% in 2023, then soared by 55bps to 0.86% in 2024, then crashed by -218bps to 2.72% in 2025.
  • Its Return on Equity stands at 2.72% for Q4 2025, versus 2.78% for Q3 2025 and 1.79% for Q2 2025.